The Hong Kong Patent Office granted HK Patent No. HK40097814 to Envoy Medical Corporation on January 3, 2025. The title is Programming of Cochlear Implant Accessories. This patent relates to a system ...

Inc. (NASDAQ: COCH), a small-cap medical device company with a market capitalization of $29.4 million specializing in hearing loss solutions, has announced the expansion of its patent portfolio with ...

The hypothesized role of ovarian hormones and cardiovascular disease in hearing loss is reviewed, and such interventions as cochlear implants to correct hearing loss in women are highlighted.

The Cochlear Ltd (ASX: COH) share price fell to a 52-week low last week, dropping to $261.38 after the company reported its FY25 half-year result. The ASX healthcare company's half-year result ...

Cochlear shares fell as much as 12% after a second consecutive earnings miss, with earnings impacted by cost-of-living pressures delaying customer upgrades 1H25 revenue and profit missed expectations, ...

However, they cannot restore binaural hearing. Cochlear implants can restore binaural hearing, producing significant improvements in speech perception, spatial localization of sound, tinnitus control, ...

Manufacture and sale of Cochlear implant systems.